Trial Profile
Treatment of pancreatic adenocarcinoma with the combinationof carboplatin and velparib
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Jan 2017
Price :
$35
*
At a glance
- Drugs Veliparib (Primary) ; Carboplatin
- Indications Adenocarcinoma; Pancreatic cancer
- Focus Therapeutic Use
- 06 Jan 2017 Status changed from recruiting to completed.
- 14 Oct 2014 New trial record